Post by Isomorphic Labs

Next week, Sarah Skerratt, FRSC Skerratt, Chief Research Officer at Isomorphic Labs, will be in Washington D.C. for Revolution 2026. She’ll join a panel of industry leaders to talk about how AI is being used in drug discovery today, what the future might hold, and the responsibility we all share to innovate thoughtfully.  She’ll also share how our drug design engine (IsoDDE) is helping us explore new areas of chemistry and biology that have traditionally been out of reach, speeding up the path from early research to potential new medicines. Head to the comments for the agenda.